Force Feedback Joystick in Upper Limb Rehabilitation Following Stroke
NCT ID: NCT00758147
Last Updated: 2008-09-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
30 participants
INTERVENTIONAL
2008-11-30
2010-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The aim of the study in this application is to test the usability of the system in specialized rehabilitation hospital settings. In this first stage of development, after developing and testing the system together with expert physiotherapists, we will examine the system for usability (is it "user friendly"), comfort level, and therapeutic efficacy.
The system consists of an ordinary PC computer, specially written software, and a commercially available force feedback joystick. (Force feedback joysticks, are usually used for gaming; they contain miniature motors that allow the joystick to either help or resist the movements of the person using it). Patients who are unable to grasp the joystick will use a specially built arm rest that is attached to an ordinary office chair without wheels. Patients rest their forearm on the arm rest and thus can manipulate the joystick by means of movement of the shoulder and elbow joints instead of by movements of the wrist, since wrist movements are often difficult for brain damaged individuals.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
CROSSOVER
TREATMENT
SINGLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Exercise with force feedback joystick
System consists of a commercially available force feedback joystick, and specially written software. Patients will work with the system 5 times a week for 4 weeks, a half hour each time, 2 weeks with visual and haptic feedback and 2 weeks without the feedback.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Score of more than 17 on the Mini Mental Scale Test(MMST)
Exclusion Criteria
* Inability to understand the informed consent form
* Inability to understand and follow 2-3 step instructions
* Receptive aphasia (sensory aphasia)
65 Years
86 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ono Academic College
OTHER
Rabin Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Beit Rivka Geriatric Center
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Shai Brill, M.D.
Role: PRINCIPAL_INVESTIGATOR
Beit Rivka Geriatric Hospital
Heidi Sugarman, PhD
Role: STUDY_DIRECTOR
Ono Academic College
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Beit Rivka Geriatric Hospital
Petah Tikva, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Shai Brill, M.D.
Role: primary
Riki Brown, MSc
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BGC085012CTIL
Identifier Type: -
Identifier Source: org_study_id